About Cmed
Cmed is a company based in Horsham (United Kingdom) founded in 1999. Cmed has raised $10 million across 1 funding round from investors including Scottish Equity Partners. The company has 225 employees as of January 31, 2020. Cmed operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and Clinical Ink, among others.
- Headquarter Horsham, United Kingdom
- Employees 225 as on 31 Jan, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cmed Group Limited
-
Annual Revenue
$25.08 M (USD)12as on Dec 31, 2019
-
Net Profit
$1.96 M (USD)5as on Dec 31, 2019
-
EBITDA
$1.95 M (USD)5as on Dec 31, 2019
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series A
Dec 15, 2008
- Investors
-
Employee Count
225
as on Jan 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cmed
Cmed has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in December 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cmed
Cmed has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Scottish Equity Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech companies
|
Locked | Locked | Locked |
Investor details for Cmed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cmed
Investment portfolio details for Cmed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cmed
Detailed financials for Cmed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cmed Comparisons
Peer comparison for Cmed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cmed
Cmed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and Clinical Ink, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
|
|
| Locked | Locked | Locked |
AI-based solutions for health management are provided.
|
|
| Locked | Locked | Locked |
Clinical trial management software is provided for researchers and professionals.
|
|
| Locked | Locked | Locked |
Signant Health is engaged in providing clinical trial technology solutions.
|
|
| Locked | Locked | Locked |
Paperless eSource and patient engagement solutions for clinical trials
|
|
| Locked | Locked | Locked |
Regulatory and ethical review services for clinical research are provided.
|
Detailed competitors of Cmed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cmed
Complete news archive for Cmed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cmed
Cmed was founded in 1999 and raised its 1st funding round 9 years after it was founded.
Cmed is headquartered in Horsham, United Kingdom. It is registered at Horsham, West Sussex, United Kingdom.
Cmed is a funded company, having raised a total of $10M across 1 funding round to date.
As of Jan 31, 2020, the latest employee count at Cmed is 225.
Annual revenue of Cmed is $25.08M as on Dec 31, 2019.
Cmed provides solutions for clinical trial management. It has a services branch and a technology branch. Services include clinical services, regulatory, consulting and product development, data and analytics, medical services, clinical operations and study start-up. They claim to have an expertise in conducting complex, oncology and rare disease trials. They claim to have conducted over 100 oncology trials. Products include encapsia- Clinical Data Suite which can be used to collect, query, clean, visualize and analyze clinical data in real time and Timaeus - a platform for clinical data management and electronic data capture.
Cmed has 1 investor. Key investors include Scottish Equity Partners.